Literature DB >> 24121619

High prevalence of CYP2D6*41 (G2988A) allele in Saudi Arabians.

Mohammed S Al-Dosari1, Fahad I Al-Jenoobi, Khalid M Alkharfy, Amal M Alghamdi, Khawla M Bagulb, Mohammad K Parvez, Abdullah M Al-Mohizea, Saleh Al-Muhsen, Rabih Halwani.   

Abstract

The main objective of this study was to evaluate CYP2D6 genetic polymorphism in a Saudi Arabian population by determining the frequencies of CYP2D6*41, CYP2D6*29, CYP2D6*3, CYP2D6*6 and CYP2D6*14 alleles. Genomic DNA was isolated from 192 healthy Saudis representing different geographical regions, and genotyping of the selected CYP2D6 variants was carried out by direct sequencing. The allelic frequency of CYP2D6*41 was found to be 18.4%, and that of CYP2D6*29 to be 2.9%. The other investigated alleles were either not detected or rarely present in the study population. In addition, two commonly shared single nucleotide polymorphisms (SNPs) and two very rare SNPs among CYP2D6 alleles were detected. Further studies are therefore, required to evaluate the metabolic and clinical relevance of CYP2D6*41 in Saudi Arabians.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allele frequency; CYP2D6; Polymorphism; Saudi Arabians

Mesh:

Substances:

Year:  2013        PMID: 24121619     DOI: 10.1016/j.etap.2013.09.008

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  6 in total

1.  CYP2D6 allele distribution in Macedonians, Albanians and Romanies in the Republic of Macedonia.

Authors:  M Kuzmanovska; M Dimishkovska; I Maleva Kostovska; P Noveski; E Sukarova Stefanovska; D Plaseska-Karanfilska
Journal:  Balkan J Med Genet       Date:  2016-07-09       Impact factor: 0.519

2.  Single nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population.

Authors:  Ha Hai Nguyen; Thuong Thi Huyen Ma; Nhung Phuong Vu; Quynh Thi Nhu Bach; Thang Hong Vu; Ton Dang Nguyen; Hai Van Nong
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 3.  Frequencies of CYP2D6 genetic polymorphisms in Arab populations.

Authors:  Mousa Alali; Wouroud Ismail Al-Khalil; Sara Rijjal; Lana Al-Salhi; Maher Saifo; Lama A Youssef
Journal:  Hum Genomics       Date:  2022-02-05       Impact factor: 4.639

4.  The impact of CYP2D6*41 on CYP2D6 enzyme activity using phenotyping methods in urine, plasma, and saliva.

Authors:  Ye Jin; Shuquan Zhang; Pei Hu; Xin Zheng; Xiaoduo Guan; Rui Chen; Shuyang Zhang
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

5.  Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.

Authors:  Mohammad A Alshabeeb; Mesnad Alyabsi; Bien Paras
Journal:  Saudi Pharm J       Date:  2022-06-22       Impact factor: 4.562

6.  Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?

Authors:  Milena Gusella; Felice Pasini; Barbara Corso; Laura Bertolaso; Giovanni De Rosa; Cristina Falci; Yasmina Modena; Carmen Barile; Donatella Da Corte Z; AnnaPaola Fraccon; Silvia Toso; Elisabetta Cretella; Antonella Brunello; Caterina Modonesi; Romana Segati; Cristina Oliani; Nadia Minicuci; Roberto Padrini
Journal:  Pharmacol Res Perspect       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.